Pinion Investment Advisors LLC Lowers Stock Position in Kenvue Inc. $KVUE

Key Points

• Pinion Investment Advisors LLC reduced its stake in Kenvue Inc. by 48.5% in the second quarter, now holding 36,711 shares worth $768,000.
• Kenvue increased its quarterly dividend to $0.2075 per share, representing an annualized yield of 4.9%, despite a net margin drop to 9.37% for the quarter.
• Analysts have varied ratings on Kenvue, with one research firm upgrading it to a "strong buy" while others have set price targets as low as $17.00 and as high as $27.00.

Pinion Investment Advisors LLC lessened its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 48.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,711 shares of the company's stock after selling 34,591 shares during the quarter. Pinion Investment Advisors LLC's holdings in Kenvue were worth $768,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of KVUE. Capital Investment Advisors LLC raised its position in Kenvue by 16.4% in the 1st quarter. Capital Investment Advisors LLC now owns 13,261 shares of the company's stock worth $318,000 after buying an additional 1,869 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Kenvue by 33.2% during the 1st quarter. GAMMA Investing LLC now owns 24,778 shares of the company's stock valued at $594,000 after purchasing an additional 6,169 shares during the period. Assenagon Asset Management S.A. grew its stake in shares of Kenvue by 4.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 884,348 shares of the company's stock valued at $21,207,000 after purchasing an additional 40,447 shares during the period. CX Institutional bought a new stake in shares of Kenvue during the 1st quarter valued at about $185,000. Finally, Focus Financial Network Inc. grew its stake in shares of Kenvue by 9.5% during the 1st quarter. Focus Financial Network Inc. now owns 12,624 shares of the company's stock valued at $303,000 after purchasing an additional 1,095 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Kenvue Price Performance

Shares of KVUE stock opened at $16.83 on Friday. The stock's 50-day moving average is $19.25 and its 200 day moving average is $21.38. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. Kenvue Inc. has a 1-year low of $15.47 and a 1-year high of $25.17. The company has a market cap of $32.30 billion, a P/E ratio of 22.74, a PEG ratio of 2.31 and a beta of 0.72.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The company had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.94 billion. During the same period last year, the business posted $0.32 earnings per share. The firm's revenue was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.9%. This is a boost from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 13th. Kenvue's dividend payout ratio (DPR) is 112.16%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Zacks Research upgraded Kenvue to a "strong sell" rating in a research note on Monday, August 11th. Rothschild Redb raised Kenvue from a "hold" rating to a "strong-buy" rating in a report on Friday, September 26th. JPMorgan Chase & Co. lowered their price target on Kenvue from $27.00 to $26.00 and set an "overweight" rating on the stock in a report on Friday, July 25th. Barclays decreased their price objective on Kenvue from $20.00 to $17.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Finally, Bank of America cut their price objective on Kenvue from $25.00 to $21.00 and set a "buy" rating on the stock in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Kenvue has a consensus rating of "Hold" and an average price target of $21.54.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.